STAT1 and neoplasm: In other cell types, AXL has been shown to block STAT1-dependent responses (Rothlin et al., 2007), thus it is tempting to speculate it may similarly function to block the STAT1 tumor suppressor in CSCs, enhancing CIN tolerance.